<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02454660</url>
  </required_header>
  <id_info>
    <org_study_id>1R21HS022336-01A1</org_study_id>
    <nct_id>NCT02454660</nct_id>
  </id_info>
  <brief_title>Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages</brief_title>
  <acronym>AIM@BP</acronym>
  <official_title>Improving Adherence and Outcomes by Artificial Intelligence-Adapted Text Messages</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Uncontrolled hypertension is a major cause of morbidity and mortality and many patients fail
      to take their antihypertensive medication as prescribed. The investigators propose to use
      artificial intelligence (AI) to allow short message service (SMS or text messages)
      interventions to adapt to patients' adherence needs and substantially improve medication
      taking. The aims of the study are to: (1) develop AI methods for adaptive decision-making in
      human-centered environments and demonstrate the feasibility of the resulting AI-enhanced SMS
      medication adherence intervention, (2) demonstrate that the intervention can &quot;learn&quot; by
      adapting the SMS message stream according to patients' medication taking over time, and (3)
      examine potential intervention impact as measured by improvements in medication adherence and
      systolic blood pressures. The investigators will recruit 100 patients with uncontrolled
      hypertension and antihypertensive medication non-adherence. Adherence and other covariates
      will be measured via surveys at baseline, 3- and 6 months; blood pressures will be measured
      at baseline and 6 months. Participants will be given an electronic pill-bottle adherence
      monitor. Participants will receive SMS messages designed to motivate antihypertensive
      medication adherence. Message content and frequency will adapt automatically using AI
      algorithms designed to automatically optimize expected pill bottle opening. For Aim 1, the
      first 25 patients will be enrolled to develop and test alternative RL algorithms and
      fine-tune the system parameters. For Aim 2, the investigators will examine changes in the
      probability distribution over message-types and compare that distribution with patients'
      reasons for non-adherence reported at baseline. For Aim 3, the investigators will examine
      changes in self-reported medication non-adherence and blood pressure and
      automatically-reported pill bottle openings. This pilot study will establish the feasibility
      and potential impact of this novel approach to mobile health messaging for self-management
      support. The results will be used to support an R01 application for a larger and more
      definitive trial of intervention impacts.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Self-management of chronic conditions involves complex behaviors, and patients vary in their
      adherence to these behaviors. The focus of this proposal is medication adherence because
      patients' failure to take their medications as prescribed is a major cause of excess
      morbidity and mortality and increased health care costs. Studies suggest that 33-50% of
      patients do not take their medications properly, contributing to nearly 100,000 premature
      deaths each year and $290 billion in health care costs. Adherence to antihypertensive
      medications is of particular importance in its own right, and hypertension can serve as an
      important tracer condition to better understand and improve medication adherence more
      generally. Uncontrolled hypertension is a major cause of stroke, coronary heart disease,
      heart failure and mortality, and medication non-adherence is a major cause of uncontrolled
      hypertension. For example, in a one-year study of ~5,000 hypertensive patients, most patients
      took their medications only intermittently with half of patients eventually discontinuing
      their medications against medical advise.

      Improving medication adherence requires addressing multiple challenges because patients
      typically have a variety of reasons for not taking their medication as prescribed, such as
      beliefs about their disease and its treatment, organizational challenges, and cost barriers.
      Moreover, as patients' regimens, health status, and social context change over time,
      adherence support interventions need to adapt, but most services lack the flexibility to do
      so.

      Mobile health (mHealth) services such as patient text messaging or SMS have shown some
      promise in improving medication adherence. However, since almost all mHealth services are
      based on simplistic, deterministic protocols, these interventions lack the capacity to meet
      patients' complex changing needs. As a consequence, these rudimentary systems have
      demonstrated only modest effects that tend to decrease over time. The investigators propose
      to apply artificial intelligence (AI) methods, specifically Reinforcement Learning (one type
      of AI), to develop a model medication adherence system that can automatically adapt SMS
      communication to improve individual medication taking.

      The proposed project is the result of a new multidisciplinary collaboration between UM
      experts from the College of Pharmacy, College of Engineering, and School of Medicine. Our
      long-term goal is to improve health outcomes using artificial intelligence (AI) enhanced
      mobile health tools. The objective in the proposed pilot study is to develop a Reinforcement
      Learning-based mHealth program focused on medication adherence among patients with poorly
      controlled hypertension. Our central hypotheses are that a SMS system that uses Reinforcement
      Learning (RL) will: be acceptable to patients, adapt to hypertension patients' unique
      adherence-related needs and preferences and changes in these needs over time, and improve
      medication adherence and blood pressure control. The specific aims are:

        1. Develop RL methods for adaptive decision-making in human-centered environments and
           demonstrate the feasibility of the resulting RL-based adaptive SMS medication adherence
           intervention,

        2. Demonstrate &quot;learning&quot; by the RL-base adaptive system using data showing adaptation of
           the SMS message stream according to variation across patients and over time in the
           reasons for non-adherence, and

        3. Examine the potential efficacy of the RL-based adaptive SMS intervention with respect to
           improvements in medication adherence and systolic blood pressure.

      The results of this pilot project will include a novel AI/RL technology and evidence
      regarding its real-world use based on experience with a sample of adults with poorly
      controlled hypertension. These results will be used to support an R01 application for a
      larger and more definitive study of the intervention's impact on patients' health and
      long-term adherence behaviors. Over the longer term, this AI-enhanced mHealth self-management
      support infrastructure and unprecedented collaboration between investigators in Pharmacy,
      Medicine, and Computer Science will lay the foundation for a larger program of NIH-funded
      research using similar AI approaches to addressing behavior change challenges in a large
      number of health and healthcare problems.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">November 4, 2016</completion_date>
  <primary_completion_date type="Actual">November 4, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Medication Adherence (Proportion Days Covered (PDC)) assessed by administrative insurance records</measure>
    <time_frame>2 years</time_frame>
    <description>A measure of Proportion Days Covered (PDC) and is assessed administrative insurance records</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported medication adherence assessed via a questionnaire</measure>
    <time_frame>baseline, 3 months and 9 months</time_frame>
    <description>Medication adherence is collected at these time points and assessed via a questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pill bottle openings (how often medication was taken) assessed by records from pill bottle caps (MEMS readers)</measure>
    <time_frame>9 months</time_frame>
    <description>proxy measure of how often medication was taken, assessed by records from pill bottle caps (MEMS readers)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Beliefs assessed via a questionnaire</measure>
    <time_frame>baseline, 3 months and 9 months</time_frame>
    <description>A measurement of the patients beliefs about the medication they take will be collected at these time points and assessed via a questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Medication Non-adherence</condition>
  <arm_group>
    <arm_group_label>SMS (Text messaging)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive text messages during their entire enrollment period in the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No SMS (No text messages)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will not receive text messages during their entire enrollment period in the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS (Text messages)</intervention_name>
    <description>Up to 1 text message a day. The artificial agent will determine whether to send a message each day. If it sends a message, it will also determine which of five message types to send.</description>
    <arm_group_label>SMS (Text messaging)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must have Priority Health Care Health Insurance Coverage

          -  Patient must have PDC of &lt; 0.5 for anti-hypertensive medications

        Exclusion Criteria:

          -  No hypertension medicine currently taken

          -  Patient doesn't text message (no cell phone) in an average week

          -  No access to the internet

          -  Patient has heart failure which makes it difficult to catch breath and move around

          -  Patient uses artificial oxygen to breathe

          -  Patient is currently under treatment for cancer

          -  Patient currently has kidney disease that requires dialysis

          -  Patient self reports a mental health diagnosis (from a health professional)

          -  Patient reports having schizophrenia

          -  Patient reports currently being treated bipolar disorder or manic-depressive illness
             or schizophrenia

          -  Patients reports ever been diagnosed with dementia or Alzheimer's disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen Farris, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univerity of Michigan, College of Pharmacy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan College of Pharmacy</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lawn S, Schoo A. Supporting self-management of chronic health conditions: common approaches. Patient Educ Couns. 2010 Aug;80(2):205-11. doi: 10.1016/j.pec.2009.10.006. Review.</citation>
    <PMID>19931372</PMID>
  </reference>
  <reference>
    <citation>Coleman MT, Newton KS. Supporting self-management in patients with chronic illness. Am Fam Physician. 2005 Oct 15;72(8):1503-10. Review.</citation>
    <PMID>16273817</PMID>
  </reference>
  <reference>
    <citation>Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487-97. Review.</citation>
    <PMID>16079372</PMID>
  </reference>
  <reference>
    <citation>NEHI. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease. http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_disease, Accessed 09 12 12</citation>
  </reference>
  <reference>
    <citation>Hill MN, Miller NH, Degeest S; American Society of Hypertension Writing Group, Materson BJ, Black HR, Izzo JL Jr, Oparil S, Weber MA. Adherence and persistence with taking medication to control high blood pressure. J Am Soc Hypertens. 2011 Jan-Feb;5(1):56-63. doi: 10.1016/j.jash.2011.01.001. Review.</citation>
    <PMID>21320699</PMID>
  </reference>
  <reference>
    <citation>Munger MA, Van Tassell BW, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed. 2007 Sep 19;9(3):58. Review.</citation>
    <PMID>18092064</PMID>
  </reference>
  <reference>
    <citation>Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008 May 17;336(7653):1114-7. doi: 10.1136/bmj.39553.670231.25. Epub 2008 May 14.</citation>
    <PMID>18480115</PMID>
  </reference>
  <reference>
    <citation>Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011. doi: 10.1002/14651858.CD000011.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD000011.</citation>
    <PMID>18425859</PMID>
  </reference>
  <reference>
    <citation>Marx G, Witte N, Himmel W, KÃ¼hnel S, Simmenroth-Nayda A, Koschack J. Accepting the unacceptable: medication adherence and different types of action patterns among patients with high blood pressure. Patient Educ Couns. 2011 Dec;85(3):468-74. doi: 10.1016/j.pec.2011.04.011. Epub 2011 May 19.</citation>
    <PMID>21600724</PMID>
  </reference>
  <reference>
    <citation>Sabate E - World Health Organization. Adherence to long-term therapies: evidence for action. 2003. http://apps.who.int/medicinedocs/en/d/Js4883e/, Accessed 09 12 12</citation>
  </reference>
  <reference>
    <citation>Elliott RA, Shinogle JA, Peele P, Bhosle M, Hughes DA. Understanding medication compliance and persistence from an economics perspective. Value Health. 2008 Jul-Aug;11(4):600-10. doi: 10.1111/j.1524-4733.2007.00304.x. Epub 2008 Jan 8.</citation>
    <PMID>18194403</PMID>
  </reference>
  <reference>
    <citation>Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012 Sep-Oct;19(5):696-704. doi: 10.1136/amiajnl-2011-000748. Epub 2012 Apr 25. Review.</citation>
    <PMID>22534082</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2015</study_first_submitted>
  <study_first_submitted_qc>May 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2015</study_first_posted>
  <last_update_submitted>April 7, 2017</last_update_submitted>
  <last_update_submitted_qc>April 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Karen Farris, PhD.</investigator_full_name>
    <investigator_title>Charles R. Walgreen Professor of Pharmacy Administration</investigator_title>
  </responsible_party>
  <keyword>adherence</keyword>
  <keyword>hypertension</keyword>
  <keyword>mobile technology</keyword>
  <keyword>intervention</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

